期刊
NEUROPHARMACOLOGY
卷 93, 期 -, 页码 134-145出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2015.01.027
关键词
Alzheimer's disease; Quercetin; Neuroprotection; Tauopathy; beta-amyloidosis; Cognitive function
资金
- COLCIENCIAS [111551928905]
- CODI University of Antioquia
- Young Investigator Programme Colciencias
- NIA/NIH [1 R01 AG029802-01]
Alzheimer's disease (AD) is the most common senile dementia in the world. Although important progress has been made in understanding the pathogenesis of AD, current therapeutic approaches provide only modest symptomatic relief. In this study, we evaluated the neuroprotective effect of quercetin (25 mg/kg) administration via i.p. injection every 48 h for 3 months on aged (21-24 months old) triple transgenic AD model (3xTg-AD) mice. Our data show that quercetin decreases extracellular beta-amyloidosis, tauopathy, astrogliosis and microgliosis in the hippocampus and the amygdala. These results were supported by a significant reduction in the paired helical filament (PHF), beta-amyloid (beta A) 1-40 and beta A 1-42 levels and a decrease in BACE1-mediated cleavage of APP (into CTF beta). Additionally, quercetin induced improved performance on learning and spatial memory tasks and greater risk assessment behavior based on the elevated plus maze test. Together, these findings suggest that quercetin reverses histological hallmarks of AD and protects cognitive and emotional function in aged 3xTg-AD mice. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据